Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, mô bệnh học và hóa mô miễn dịch ung thư biểu mô tế bào gan có huyết khối tĩnh mạch cửa ttta

27 71 0
  • Loading ...

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Tài liệu liên quan

Thông tin tài liệu

Ngày đăng: 18/09/2019, 11:37

MINISTRY OF EDUCATION MINSITRY OF NATIONAL AND TRAINING DEFENCE 108 INSTITUTE OF CLINICAL MEDICAL AND PHARMACEUTICAL SCIENCES TRINH XUAN HUNG STUDY OF CLINICAL AND PARACLINICAL, HISTOPATHOLOGY AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN THROMBOSIS Speciality: Internal Gastroenterology Code: SUMMARY OF DOCTORAL THESIS IN MEDICINE HANOI – 2019 THE DISSERTATION WAS COMPLETED AT 108 INSTITUTE OF CLINICAL MEDICAL AND PHARMACEUTICAL SCIENCES Supervisor: Professor Mai Hong Bang MD., PhD Associate professor Trinh Tuan Dung MD., PhD The 1st reviewer: The 2nd reviewer: The 3rd reviewer: The doctoral thesis was protected in front of the thesis review committee at 108 Institute of Clinical Medical and Pharmaceutical Sciences The thesis can be founded in: - National library - Scientific Research Institute of Clinical Medicine and Pharmacy 108’s library THE LIST OF PUBLISHCATION RESULTS OF THE THESIS Trịnh Xuân Hùng, Mai Hồng Bàng, Trịnh Tuấn Dũng, Nguyễn Tiến Thịnh (2019), “Results of portal vein thrombus biopsy in patients with advanced hepatocellular carcinoma”, Journal of 108 – Clinical medicine and pharmacy, volume 14 (N 5/2019), 1-7 Trịnh Xuân Hùng, Mai Hồng Bàng, Trịnh Tuấn Dũng, Nguyễn Tiến Thịnh (2019), “Study on clinical and laboratory features of advanced hepatocellular carcinoma in patients with vein thrombosis”, Vietnam medical journal, volume 480, 165-169 THE LIST OF ACRONYMS Acronyms Full writing AFP Alpha -Fetoprotein ALT Alanine amino transferase AST Aspartate amino transferase BCLC CT Barcelona Clinic Liver Cancer Computered tomography ECOG Eastern Cooperative Oncology Group HbsAg Hepatitis B surface Antigen HBV Hepatitis B virus HCC Hepatocellular cancer HCV Hepatitis C virus PVT Portal vein thrombosis WHO World Health Organization INTRODUCTION Hepatocellular carcinoma (HCC) is a very popular disease in the world According to GLOBOCAN data in 2018, HCC is the fifth and the ninth most commonly diagnosed cancer in men and women, respectively There will usually be an estimated 841,000 new diagnosed cases of HCC and 782,000 died cases In Vietnam, According to GLOBOCAN data in 2018, the prevalence and mortality of HCC is one of the first commonly cancer The mortality of HCC has their equivalence to compare with new diagnosed cases, this show that HCC were often diagnosed at advance stages, so the prognose and control of the disease still have difficulties The prognose of HCC is often very poor, especially, they are advance HCC with portal vein thrombosis (PVT) Previous studies show that HCC with PVT acount for 30-62.2%, the PVT also is signal point out that primary HCC is a advance HCC with poor prognosis, risk of oesophagus variceal bleeding, and hepatic failure (e.g thrombosis in trunk of portal vein) Mean survival time of pateints with HCC having PVT without treatment is very short (2.7-4 months), meanwhile that of HCC having not PVT without treatment is 24.4 months Detection of PVT, especailly benign or neoplastic PVT in new diagnosed HCC has key meaning for prognosis as well as making choice of treatment methods There are no any work to study systematicaly characteristics of histopathology and immunohistochemistry of PVT in patients with HCC in Vietnam as well as in the world From the mention above, we carried out the project with objectives: 1- assessment of clinical characteristics, paraclinical tests, imaging diagnoses of HCC pateints with PVT 2- analysis of imaging, histopathology and immunohistochemistry characteristics of PVT, and safe biopsic technic, supplemental survival time and involving factors in pateins with PVT * Thesis layout: The thesis has 123 pages, including: Introduction (2 pages), Chapter 1: Overview (36 pages), Chapter 2: Subjects and methods (20 pages), Chapter 3: Results (28 pages), Chapter 4: Discussion (34 pages), Conclusion (2 pages), Recommendations (1 page) The thesis has 34 tables, 26 images The thesis has 141 references: 21 Vietnamese references and 127 English references * The new main contributions of the thesis In Vietnam, this is the first study that biospy of PVT was carried out in HCC pateints, assessment of deffirentiation of PVT, staining immunohistochemistry to assess angiogenesis level in PTV involving with supplemental survival time The benign or malignant PVT are also standards for indication and contraindication of some HCC treating methods Therefore, the thesis has very reliable and scientific meanings in clinical practise The results of project shown that, the biospy of PVT in HCC patients is pretty safe technic with less complications (it is a problem that professionals are previously hesitant to mention) CHAPTER I: OVERVIEW 1.1 Epidemiology of hepatocellular carcinoma in the world and Vietnam HCC is the very common malignant disease, it is commonly detected in late stage, very poor prognosis, and high mortality in short time The estimated 500.000-1.000.000 new cases of HCC, and estimated 600.000 died cases worldwide Frome GLOBOCAN data in 2018, HCC is leading cancer in Vietnam, new HCC incidence as well as mortality are higher than lung cancer and stomach cancer, approcimately 25.335 new diagnosed cases and the mortality of HCC, acount for 15.4% and 21.5% (19.568 cases) of total of cancer, respectively Therefore, nowadays, the trend of HCC have been increasing according to the time and this is indeed a hude challenge for medicine in my country 1.2 Diagnosis of hepatocellular carcinoma 1.2.1.Clinical symptoms The clinical symptoms of HCC are often present in late stage of the disease because of good functional balance of liver 1.2.2 Marker of hepatocellular carcinoma Alpha-Fetoprotein is a tumer marker for HCC that is used most in diagnose of HCC 1.2.3 Imaging diagnose of HCC Ultrasound : This is the leading technic for screening localized lesions in the liver, including: B-mode ultrasound, doppler ultrasound, Contrast - enhanced Ultrasound Computed tomography scan: Nowadays, this is the most widely used technique to diagnose HCC Multi-sequential 3-dimensional CT scan (artery stage, portal vein and late stage) is considered a standard technique for HCC diagnosis Magnetic resonance imaging: providing very good characteristics of typical angiogenesis of HCC with sensitivity and specificity up to 90-95% In addition, there are also somme technique such as: Digital Subtraction Angiography and positron emission tomography/computer tomography (PET/CT) 1.2.4 Anapathology The differentiation level of HCC cells: according to Edmondson and Steiner, Armed Forces Institute of Pathology as well as the World Health Organization, differentiation level of HCC cells was often divided into different levels: high and medium , low and non-differentiated levels basing on ratio of nucleus/cytoplasm 1.2.5 Diagnostic criteria of hepatocellular carcinoma - The diagnotic and follow-up process is more simplified in American Liver Foundation's guidelines in 2011 - According to the guidelines of Vietnam Ministry of public Health in 2012: • There are Anapathologic criteria of HCC • Diagnosing images of abdominal CT scans with contrast agent or abdominal MRI with contrast agent + AFP concentration is higher than normal, but less than 400 ng/mL + B or C hepatitis 1.3 Portal vein thrombosis Portal vein thrombosis can occur in many different diseases, but the most common is cirrhosis with HCC Other diseases, including: other cancer diseases, bone marrow disorders, bacterial infection, post-surgery, estrogen treatment, and portal hypertension without cirrhosis 1.3.1 Frequency of portal vein thrombosis The PVT frequency of 10-25 % for solitary cirrhosis, a result of study with a large sample size of 701 solitary cirrhotic patients showed that the prevalence of PVT in solitary cirrhotic patient of 11% The frequency of PVT in HCC is much higher than others, with the detected rate of PVT of advance HCC of 40 to 90.2% A result of retrospective cohort study with 336 HCC patients in Thailand showed PVT rate of 50% The rate of 31% of another study with 194 patients was carried out in the United States 1.3.2 Pathogenesis of portal vein thrombosis PVT is due to reducing flow rate of the portal vein system, vascular endothelial damage and coagulopathy in cirrhosis In addition to cirrhosis, HCC also directly invades the portal vein system, or metastasis of cancer cells into the portal system is considered a most essential factor for a formation of malignant PVT The development of cancer tissue with platelet aggregation inside the vein facilitate thrombosis to develop and spread In addition, the compression of the tumor in the portal vein system enhances to obstruct the flow rate, which is also a factor to motivate formation of thrombosis 1.3.3 Diagnosis of portal vein thrombosis In order to detect and diagnose PVT, imaging diagnosis plays a extreme key role, however, the result of cell aspiration with small needle or biospy of thrombosis are considered a gold standard of the diagnose Imaging diagnosis In order to diagnose malignant PVT basing on signs, including: appearance of a clear invasive image of tumor into the lumen, a stretch of the portal vein of 23 mm or more and angiogenesis in PVT Histopathology and immunohistochemistry tests Histopathology test of PVT is a gold standard of diagnosis of benign PVT or malignant PVT Differentiation level of PVT as well as tumor in liver were devided into separated levels, including: high, medium, and low, and nondifferentiation However, in some suspicious cases, especially poor or non-differentiated PVT immunohistochemistry can be used to determine whether PVT derived from HCC Immunohistochemistry is also significant for assessment of vessels as well as level of angiogenesis in PVT Basic methods for selecting PVT specimens: * Cell aspiration using small needle according to the ultrasound guide * Biopsy: selecting PVT specimens by using a biopsy gun (FAST gun) * Surgery: dissection of the liver and selecting PVT specimens 1.3.4 Treatment of HCC with PVT The standard drug for treatment in the stage with preserved liver function is Sorafenib Some recent clinical trials have shown that HCC with PVT can also consider for surgery, injection with 100% alcohol in thrombosis, Transarterial radioembolization (TARE) with yttrium-90microspheres, stereotactic body radiation therapy using CyberKnife CHAPTER II: Subjects and methods 2.1 Subjects: 101 patients with PVT were diagnosed at 108 Central Military Hospital from 8/2012 to 12/2017 2.1.1 Subject Selection -The patients were positively diagnosed HCC according to one of three criteria of the Vietnam Ministry of Health in 12/2012 below: + HCC with PVT + Coagulation function: prothrombin ≥ 60%; number of phlatelet ≥ 60.000/mm3 + General status of patient (ECOG): from to scores (WHO) - Age: from 18 to 90 years old - No gender inequality - The patients agree to take part in the study in writing for assurance BenchMark Ultra automatic dyeing machine (United States) Depending on specific cases, it could be dyed by markers, including: Hepar-1, Hepatocyte, AFP, CK7, CK 20, CDx2, Vimentin, Chromogranin, NSE, Synaptophysin and so on; assessment of angiogenesis in thrombosis using additional markers such as CD31 and CD34 * Post-biopsy monitoring: Some common side effects were liver pain and fever Monitoring of severe complications (bleeding, perforation, ) mornitoring of extra-survival time, the patient could be whether or not interventionally treated according to the hospital cancer council 2.2.5 Research criteria Clinical and paraclinical examinations * Clinical criteria: - Age: The patients were devided into groups, including: under ages 40; ages 41to 60, and ages 60 and older - Gender: men, women - Risk factors, other diseases - Clinical symptoms: - Using The ECOG Performance Status as one such measurement to assess how a patient's disease was progressing, including: level 0, 1, and * Paraclinical criteria: - Hematology tests, biochemical tests, immunology tests - AFP was divided levels: AFP ≤ 25IU / ml, AFP> 25 - 200 IU / ml, AFP> 200-400 IU / ml, AFP> 400 IU / ml (1IU / ml = 0.92ng / ml) - Gastroscopy: The classification of esophageal varices (normal esophageal varices, grade I, II, III) Criteria of imaging diagnosis * Characteristics of liver tumors: location, number, size, u properties 10 * PVT characteristics: location, size, properties - Classification of PVT according to Japan Cancer Research Association (2015), including: + GradeVp0: no thrombosis in lumen of portal vein + Grade Vp1: thrombosis appeared in distant branch of portal + Grade Vp2: thrombosis appeared in the 2nd branch of portal vein + Grade Vp3: thrombosis appeared in the first branch of portal vein + Grade Vp4: thrombosis appeared in the major trunk of portal vein Criteria of cirrhosis stages - Cirrhosis stages according to Child- Pugh - HCC stages according to Okuda - HCC stages according to Barcelona system of PVT histopathology and immunohistochemistry Specimens were collected by biopsy through the skin and surgery * Benign or malignant thrombosis * Cell differentiation of thrombosis: There were grades of differentiation (high, medium, low and nondifferentiation) * The level of angiogenesis in thrombosis according to the research convention: - Low level of angiogenesis: Total area of angiogenesis increases less than 10% area of tumor sample - Medium level of angiogenesis: Total area of angiogenesis accounts for 10% - 20% area of the tumor sample - High level of angiogenesis: Total area of angiogenesis increases much more than 20% area of the tumor sample * Characteristics of immunohistochemistry test of suspected cases * Relationship between PVT and liver tumor characteristics, cirrhosis, 11 and other related factors Post-biopsy complication Symptoms: pain, fever, fatigue, nausea, vomiting - Pain levels: mild, moderate, severe - Complications: bleeding, pleural effusion and gas, perforation of hollow organs Chỉ tiêu thời gian sống hệ số tương quan - Total survival time - Pearson correlation coefficient (r) - Relationship analysis 2.2.6 Statistical analysis: Data were analyzed using SPSS 22.0 software Statistical significance was defined as p value
- Xem thêm -

Xem thêm: Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, mô bệnh học và hóa mô miễn dịch ung thư biểu mô tế bào gan có huyết khối tĩnh mạch cửa ttta, Nghiên cứu đặc điểm lâm sàng, cận lâm sàng, mô bệnh học và hóa mô miễn dịch ung thư biểu mô tế bào gan có huyết khối tĩnh mạch cửa ttta

Từ khóa liên quan